Author:livlife2016

I am glad to send you the link to the “IFSO Position Statement on Bariatric Surgery in Class I Obesity (BMI 30-35)” published on the April issue of our official journal Obesity Surgery. The Position Statement has been written by a working group formed by Luca...

WASHINGTON, DC (updated) — Three-year results from the STAMPEDE trial indicate that bariatric surgery is better than intensive medical therapy alone when it comes to achieving glycemic control in obese patients with uncontrolled type 2 diabetes. The results "add to some fairly convincing evidence that, simply put, surgery...

Class I obesity conveys an increased risk of comorbidities, impairs physical and mental health-related quality of life, and it is associated to an increased psychosocial burden, particularly in women. The need for effective and safe therapies for class I obesity is great and not yet...